08-Feb-2022
Oxurion to Participate in the 2022 BIO CEO and Investor Conference
Oxurion to Participate in the 2022 BIO CEO and Investor Conference
Leuven, BELGIUM, Boston, MA, US – February 8, 2022 – 08.00 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will participate in the 2022 BIO CEO and Investor Conference being held at the Marriott Marquis in NYC on February 14-15 and virtually through the 17th.
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506
Last Updated: 08-Feb-2022
